Editorial
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastrointest Oncol. Dec 15, 2012; 4(12): 230-237
Published online Dec 15, 2012. doi: 10.4251/wjgo.v4.i12.230
Table 3 Randomized trials of preoperative radiation therapy combined with chemotherapy in locally advanced rectal carcinoma
Author, year publishednTreatment armsLocal recurrenceOverall survival
Gérard et al[18], 2006 (FFCD-9203)742Arm 1 (367 patients): preoperative RT (45 Gy/25 fractions/5 wk) followed by TME between 3-10 wk after RTAt 5 yr follow-up5-yr survival rate
16.5% Arm 167.9% Arm 1
Arm 2 (375 patients): preoperative RT (45 Gy/25 fractions/5 wk) + CH (2 cycles: first on days 1-5 of RT and the second on days 29-33 of RT) followed by TME between 3-10 wk after CHRT8.1% Arm 267.4% Arm 2
(P = 0.004)(P = 0.684)
Bosset et al[19], 2006 (the EORTC Radiotherapy Group Trial 22921)1011Arm 1 (252 patients): preoperative RT (45 Gy/25 fractions/5 wk) followed by TME between 3-10 wk after RT5 yr of follow-up5-yr survival rate
17.1% Arm 163.2% Arm 1
Arm 2 (253 patients): Same RT as in Arm 1 + 2 cycles of CH (days 1-5 and 29-33 of RT) + TME between 3-10 wk after CHRT8.7% Arm 263.2% Arm 2
9.6% Arm 367.2% Arm 3
Arm 3 (253 patients): Same RT as in Arm 1 + TME between 3-10 wk after RT + 4 cycles of CH postoperative7.6% Arm 467.2% Arm 4
(P = 0.002)(P = 0.12)
Arm 4 (253 patients) Same RT as in Arm 1 + 2 cycles of CH (days 1-5 and 29-33 of RT) + TME between 3-10 wk after CHRT + 2 cycles of CH postoperative
Bujko et al[20], 2005312Arm 1 (155 patients): preoperative RT (5 Gy × 5 d) followed by TME at 7 d after RT4 yr of follow-up4-yr survival rate
59% Arm 167.2% Arm 1
Arm 2 (157 patients): preoperative RT (45 Gy/25 fractions/5 wk) + 2 cycles of chemotherapy on weeks 1 and 5 of RT) followed by TME between 4-6 wk later. The cycle consisted of leucovorin 20 mg/m2 per day and, 10-20 min later, 5-fluorouracil 325 mg/m2 per day, both administered as rapid infusion on 5 consecutive days14.2% Arm 266.2% S alone
(P = 0.170)(P = 0.960)